Acute kidney injury affects up to 60 percent of intensive care patients worldwide, presenting a major challenge for critical care medicine that now has standardized clinical guidance. According to the Journal of Intensive Medicine, a multidisciplinary expert panel organized by the Chinese Society of Critical Care Medicine published comprehensive guidelines on August 18, 2026, establishing 34 clinical recommendations across seven domains to manage renal replacement therapy in critically ill adults.
Understanding Renal Replacement Therapy Standards in Modern Intensive Care
Renal replacement therapy serves as a vital life-support modality for critically ill patients experiencing severe renal complications. According to epidemiological data published in the Journal of Intensive Medicine, approximately 10 to 15 percent of intensive care unit patients with acute kidney injury progress to severe stages that require this intervention. Despite decades of clinical use, practitioners have lacked unified standards regarding core issues like treatment timing, modality selection, anticoagulation strategies, and weaning protocols.
“RRT in critically ill patients occurs within a dynamic, variable, and often hemodynamically unstable physiological environment, necessitating highly individualized and flexible RRT strategies,” stated Prof. Chen, the lead author of the guidelines. He added that unified clinical standards remained absent for core technical issues until the release of this multidisciplinary framework.
Did you know? Up to 60 percent of patients admitted to intensive care units experience varying degrees of acute kidney injury, making standardized renal support protocols critical for modern healthcare outcomes, according to global epidemiological findings cited in the Journal of Intensive Medicine.
Diagnostic Criteria and Evidence-Based Methodology
To build the 2026 clinical practice guideline, the expert panel utilized the GRADE approach for grading evidence quality through systematic literature retrieval, meta-analysis, and evidence-based medical evidence synthesis. The framework incorporates three widely recognized diagnostic and classification systems for acute kidney injury: the RIFLE criteria, the AKIN criteria, and the KDIGO guidelines. Within the published document, authors outlined 29 specific clinical questions leading to 34 distinct recommendations directed exclusively at adult patients.
The guidelines divide these recommendations into strong and weak categories based on the GRADE methodology. Key topics addressed include vascular access establishment and maintenance, treatment modality selection, specialized membrane filter applications, replacement fluid formulations, and prescribed treatment doses.
Vascular Access and Anticoagulation Regimens in Practice
Establishing reliable vascular access is crucial for continuous renal replacement therapy. According to the published guidelines, ultrasound evaluation, localization, and real-time ultrasound-guided puncture are strongly recommended during catheter placement. The right internal jugular vein or femoral vein serve as appropriate catheterization sites for renal replacement procedures.
For anticoagulation management during continuous renal replacement therapy, the expert panel established clear distinctions based on patient bleeding and metabolic risks:
- Patients without bleeding risk: Regional citrate anticoagulation is strongly recommended as the first-line strategy.
- Patients without bleeding risk but with citrate accumulation risk: Heparin anticoagulation is strongly recommended as the primary approach.
- Patients with bleeding risk: Regional citrate anticoagulation remains strongly recommended as the first-line choice.
Pro Tip: Clinicians managing high-risk intensive care patients should evaluate individual bleeding and citrate accumulation risks prior to selecting a first-line anticoagulation protocol for continuous renal replacement therapy, as outlined in the 2026 guidelines.
Timing of Initiation and Weaning Strategies
Determining when to start and stop life-support renal modalities remains a central dilemma for physicians. The guidelines recommend initiating renal replacement therapy as early as possible when patients present with life-threatening fluid overload, electrolyte disturbances, or acid-base imbalances. Furthermore, intervention should not be delayed if blood urea nitrogen levels exceed 40 millimolars per liter or if clinical manifestations of uremic encephalopathy appear.
Regarding treatment delivery, clinicians may select either continuous or intermittent renal replacement therapy based on the unique clinical condition and therapeutic goals of the individual. When considering the trial discontinuation of support, the panel suggests specific reference criteria: the recovery of urine output to over 600 milliliters within 24 hours on the day prior, or to over 1000 milliliters within 24 hours on the day of liberation.
“Through this guideline, we aim to provide scientific, standardized, and clinically actionable guidance for critical care practitioners in China, promoting standardized RRT management in adult critically ill patients with AKI,” noted Prof. Chen regarding the long-term clinical impact of the publication.
Frequently Asked Questions
What patient population do the 2026 guidelines apply to?
The clinical practice guidelines apply exclusively to adult critically ill patients experiencing acute kidney injury in intensive care settings, according to the Journal of Intensive Medicine.
What are the primary indicators for starting renal replacement therapy?
Therapy should begin promptly in patients with life-threatening fluid overload, electrolyte disturbances, acid-base imbalances, blood urea nitrogen levels exceeding 40 millimolars per liter, or clinical signs of uremic encephalopathy.
Which anticoagulation method is preferred for patients without bleeding risks?
Regional citrate anticoagulation is strongly recommended as the first-line strategy for patients without bleeding risks, provided there is no concurrent risk of citrate accumulation.
What urine output criteria suggest successful weaning from renal support?
Reference criteria for trial discontinuation include urine output recovering to over 600 milliliters in the preceding 24 hours or exceeding 1000 milliliters on the day of liberation.
Stay informed on the latest developments in critical care medicine. Subscribe to our professional newsletter or explore more clinical practice articles on our website today.
Related reading